Albemarle Corp (NYSE: ALB) is a specialty chemicals company that produces and sells lithium, bromine, and catalyst solutions. It makes money by extracting, processing, and selling these materials on a transactional basis to industrial and technology customers. As of FY2025, Albemarle operated three reportable segments: Energy Storage (lithium-based products), Specialties (bromine and related compounds), and Ketjen (refining catalysts). The Ketjen segment's Refining Solutions business was subject to a definitive divestiture agreement signed October 25, 2025, with the transaction expected to close in Q1 2026. Albemarle also completed the sale of its 50% ownership interest in Eurecat S.A. to Axens SA on January 23, 2026. Following these transactions, Albemarle will retain the PCS business and a 49% common-unit interest in the newly formed ChemCat Holdings, LP. The company's segments are organized around similar markets, customers, economic characteristics, and production processes, per the FY2025 10-K filed February 11, 2026.
Energy Storage segment: lithium compounds for battery and energy storage applications. Specialties segment: bromine and bromine-based compounds. Ketjen segment: refining catalysts, including Refining Solutions (being divested) and PCS business. 50% interest in Eurecat S.A. joint venture (sold January 23, 2026).
Transactional sales of specialty chemicals, primarily lithium compounds, bromine-based products, and refining catalysts, to industrial and technology customers across three reportable segments as of FY2025.
Customers organized by segment around similar markets and economic characteristics per FY2025 10-K. End markets include energy storage and electric vehicles (Energy Storage segment), specialty chemicals applications (Specialties segment), and petroleum refining (Ketjen segment).
The FY2025 10-K filing does not provide sufficient geographic revenue breakdown in the excerpts provided to specify regional mix.
Loading...